Product correctly added to cart.

discount label
AR-13324 mesylate
View 3D

Biosynth logo

AR-13324 mesylate

CAS: 1422144-42-0

Ref. 3D-XGC14442

2mg
136.00 €
5mg
172.00 €
10mg
248.00 €
25mg
363.00 €
50mg
518.00 €
Estimated delivery in United States, on Tuesday 4 Feb 2025

Product Information

Name:
AR-13324 mesylate
Description:

AR-13324 mesylate is an ophthalmic drug that belongs to the class of mesylates. It is a potent hypotensive agent and has shown efficacy in lowering intraocular pressure in patients with ocular hypertension or open-angle glaucoma. AR-13324 mesylate has also been found to be photostable and well tolerated by patients. The safety profile of this active compound has been demonstrated statistically, with no adverse events reported in the phase III clinical trial. AR-13324 mesylate is an active ingredient of the drug Carteolol, which is a combination of timolol maleate and AR-13324 mesylate. This combination has been shown to have a greater effect on intraocular pressure than either component alone, with decreased side effects such as photophobia, blurred vision, and tearing.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
549.64 g/mol
Formula:
C29H31N3O6S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XGC14442 AR-13324 mesylate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".